Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v1-EN
Language French English
Date Updated 2017-06-27 2017-06-27
Drug Identification Number 01912429 01912429
Brand name CLOXACILLIN SODIUM FOR INJECTION CLOXACILLIN SODIUM FOR INJECTION
Common or Proper name CLOXACILLIN CLOXACILLIN
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients CLOXACILLIN SODIUM CLOXACILLIN SODIUM
Strength(s) 500MG 500MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 500MG 500MG
ATC code J01CF J01CF
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-03-03 2017-03-03
Remaining supply date 2017-03-03 2017-03-03
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments